SNDX / Syndax Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Syndax Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US87164F1057

Utestående aktier 86,141,862 shares
Insideraktier8 067 416 shares
Insynsägande9,37 %
Totalt antal insynspersoner51
Insider Sentiment Score

Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.

Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.

Uppdateringsfrekvens: Dagligen

Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.

Office Sentiment Score

Officersentiment Score hittar företag som köps av Corporate Officers.

Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.

Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.

Uppdateringsfrekvens: Dagligen

Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.

Viktiga insidernyckeltal

Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.

Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).

Nettoantalet insiders som köper (rankning)

-3 ( )

10761 out of 11304

Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).

Procent av flytande köpta av insiders (ranking)

-0.308 %( )

10843 out of 11220

Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.

Insiderhandelsdiagram

Syndax Pharmaceuticals, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.

Insiderlista och lönsamhetsstatistik

Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.

See our leaderboard of most profitable insider traders.

Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
Biotechnology Value Fund Ii Lp - 85 038 85 038
Biotechnology Value Fund L P - 85 038 85 038
James C Blair 10% Owner - [10%] 761 062 1 743 854
Bvf Inc/il 10% Owner - [10%] 85 038 85 038
Bvf Partners L P/il 10% Owner - [10%] 85 038 85 038
BVF Partners OS Ltd. - 85 038 85 038
Biotechnology Value Trading Fund OS LP - 85 038 85 038
Botwood Nicholas A.J. Head of R&D, CMO - [O] 35 165 35 165
Henry Chen 14 000
Associates Domain 10% Owner - [10%] 27 128 27 128
Brian H Dovey 10% Owner - [10%] 761 062 1 743 854
DP VI Associates, L.P. Director, 10% Owner - [D] [10%] 13 925 13 925
DP VIII Associates, L.P. 10% Owner - [10%] 5 641 5 641
Domain Partners VI, L.P. 10% Owner - [10%] 1 743 854 1 743 854
Domain Partners VIII, L.P. 10% Owner - [10%] 761 062 761 062
Luke Evnin Director, 10% Owner - [D] [10%] 2 168 691 2 168 691
Fabrice Egros Director - [D] 32 000 32 000
Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
Todd Foley 10% Owner - [10%] 2 168 691 2 168 691
Ansbert Gadicke 10% Owner - [10%] 2 168 691 2 168 691
Neil Gallagher President, Head of R&D - [O] 85 095 85 095
Goldan Keith A. Chief Financial Officer - [O] 93 676 93 676
Brian K Halak 10% Owner - [10%] 761 062 761 062
Huber Martin H. Jr. Director - [D] 79 000 79 000
Jennifer Jarrett Director - [D] 90 000 90 000
Vaughn M Kailian 10% Owner - [10%] 2 168 691 2 168 691
Kamdar Kim P. Director, 10% Owner - [D] [10%] 8 000 27 128
Keith Katkin Director - [D] 100 000 100 000
Mark N Lampert 10% Owner - [10%] 85 038 85 038
Pierre Legault Director - [D] 90 000 90 000
MPM Asset Management Investors BV4 LLC 10% Owner - [10%] 2 168 691 2 168 691
MPM BioVentures IV GP LLC 10% Owner - [10%] 2 168 691 2 168 691
MPM BioVentures IV GmbH & Co. Beteiligungs KG 10% Owner - [10%] 2 168 691 2 168 691
MPM BioVentures IV LLC 10% Owner - [10%] 2 168 691 2 168 691
MPM BioVentures IV QP LP 10% Owner - [10%] 2 168 691 2 168 691
Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
MPM BioVentures IV Strategic Fund, L.P. 10% Owner - [10%] 2 168 691 2 168 691
Catherine Madigan 180 000
Michael A Metzger Chief Executive Officer, Director - [D] [O] 298 661 298 661
William Meury Director - [D] 90 000 90 000
Meyers Michael L. SVP, Chief Medical Officer - [O] 23 280 23 280
Briggs Morrison Director - [D] 34 836 34 836
Alexander Nolte Chief Accounting Officer - [O] 0 0
Peter Ordentlich Chief Scientific Officer - [O] 0 0
Dennis Podlesak Director - [D] 191 763 191 763
Ivor Royston Director - [D] 625 545 625 545
Aleksandra Rizo Director - [D] 25 000 25 000
James Paul Scopa 10% Owner - [10%] 2 168 691 2 168 691
Nimesh Shah 10% Owner - [10%] 27 128 27 128
Richard P Shea Chief Financial Officer - [O] 7 121 7 121
Sledge George W. Jr. 5 000
Jesse I Treu 10% Owner - [10%] 761 062 1 743 854
Nicole Vitullo 10% Owner - [10%] 761 062 1 743 854

Report errors via our new Insider Auditing Tool

Track Records av insiderköp - Kortsiktig vinstanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i SNDX / Syndax Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Max
Pris vid
Max
Maximal
vinst ($)
Maximal avkastning (%)
2025-05-19 Huber Martin H. Jr. 5 000 8,9900 5 000 8,9900 44 950 109 17.0400 40 250 89,54
2025-05-19 Katkin Keith 10 000 9,1120 10 000 9,1120 91 120
2025-05-19 Goldan Keith A. 3 000 3 000
2025-05-16 Botwood Nicholas A.J. 11 765 8,9950 11 765 8,9950 105 826
2024-06-14 Goldan Keith A. 1 250 20,0298 1 250 20,0298 25 037
2021-04-26 Meyers Michael L. 500 15,4600 500 15,4600 7 730
2021-04-22 Podlesak Dennis 13 967 14,1102 13 967 14,1102 197 077
2020-02-04 Morrison Briggs 12 500 8,0000 12 500 8,0000 100 000
2019-10-10 Morrison Briggs 11 000 5,4000 11 000 5,4000 59 400

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

SNDX / Syndax Pharmaceuticals, Inc. Insider Trades
Track Records av insiderförsäljning - Kortsiktig förlustanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i SNDX / Syndax Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Min
Pris vid
Min
Maximal förlust
undvikits ($)
Maximal förlust
undvikits ($)
2025-07-16 Goldan Keith A. 1 296 9,2850 1 296 9,2850 12 033 0 9.2500 −45 −0,37
2025-07-16 Metzger Michael A 7 534 9,2850 7 534 9,2850 69 953
2025-02-10 Gallagher Neil 4 618 15,5040 4 618 15,5040 71 597
2025-02-10 Goldan Keith A. 3 777 15,5040 3 777 15,5040 58 559
2025-02-10 Metzger Michael A 13 288 15,5040 13 288 15,5040 206 017
2023-08-09 Morrison Briggs 52 855 18,2651 52 855 18,2651 965 402
2023-08-02 Meury William 35 000 20,4556 35 000 20,4556 715 946
2023-08-02 Meury William 24 000 20,4563 24 000 20,4563 490 951
2023-08-02 Meury William 24 000 20,4547 24 000 20,4547 490 913

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

SNDX / Syndax Pharmaceuticals, Inc. Insider Trades
Transaktionshistorik

Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.

Fil
datum
Handel
datum
Schema Insider Ticker Värdepappertitel Kod 10b5-1 Direkta Utövningspris Enhet
pris
Enheter
ändrad
Värde
ändrad (1K)
Kvarvarande
Optioner
Kvarvarande
Aktier
2025-09-08 2025-09-08 4 Metzger Michael A SNDX Common Stock S - Sale D 16,4139 −157 307 −2 582 298 661
2025-09-08 2025-09-08 4 Metzger Michael A SNDX Common Stock M - Exercise D 10,9000 157 307 1 715 455 968
2025-08-18 2025-08-18 4 Podlesak Dennis SNDX Common Stock S - Sale D 15,8422 −19 200 −304 191 763
2025-08-18 2025-08-18 4 Podlesak Dennis SNDX Common Stock M - Exercise D 7,2000 19 200 138 210 963
2025-08-18 2025-08-15 4 Podlesak Dennis SNDX Common Stock S - Sale D 15,5421 −19 200 −298 191 763
2025-08-18 2025-08-15 4 Podlesak Dennis SNDX Common Stock M - Exercise D 7,2000 19 200 138 210 963
2025-08-18 2025-08-14 4 Podlesak Dennis SNDX Common Stock S - Sale D 14,1938 −19 200 −273 191 763
2025-08-18 2025-08-14 4 Podlesak Dennis SNDX Common Stock M - Exercise D 7,2000 19 200 138 210 963
2025-08-07 2025-07-31 4 Goldan Keith A. SNDX Common Stock J - Other D 8,4300 1 226 10 93 676
2025-07-18 2025-07-16 4 Metzger Michael A SNDX Common Stock S - Sale D 9,2850 −7 534 −70 298 661
2025-07-18 2025-07-16 4 Goldan Keith A. SNDX Common Stock S - Sale D 9,2850 −1 296 −12 92 450
2025-05-19 2025-05-19 4 Katkin Keith SNDX Common Stock P - Purchase D 9,1120 10 000 91 100 000
2025-05-19 2025-05-19 4 Goldan Keith A. SNDX Common Stock P - Purchase D 3 000 93 746
2025-05-19 2025-05-19 4 Huber Martin H. Jr. SNDX Common Stock P - Purchase D 8,9900 5 000 45 79 000
2025-05-19 2025-05-16 4 Botwood Nicholas A.J. SNDX Common Stock P - Purchase D 8,9950 11 765 106 35 165
2025-05-16 3 Botwood Nicholas A.J. SNDX Common Stock D 23 400
2025-03-17 2025-03-14 4 Metzger Michael A SNDX Common Stock M - Exercise D 7,2000 6 074 44 306 195
2025-03-06 2025-03-04 4 Metzger Michael A SNDX Common Stock S - Sale D 15,0453 −7 814 −118 300 121
2025-03-06 2025-03-04 4 Metzger Michael A SNDX Common Stock M - Exercise D 7,2000 7 814 56 307 935
2025-02-12 2025-02-10 4 Goldan Keith A. SNDX Common Stock S - Sale D 15,5040 −3 777 −59 90 746
2025-02-12 2025-02-10 4 Metzger Michael A SNDX Common Stock S - Sale D 15,5040 −13 288 −206 300 121
2025-02-12 2025-02-10 4 Gallagher Neil SNDX Common Stock S - Sale D 15,5040 −4 618 −72 85 095
2025-02-07 2025-02-05 4 Gallagher Neil SNDX Common Stock A - Award D 23 400 89 713
2025-02-07 2025-02-05 4 Gallagher Neil SNDX Common Stock A - Award D 18 500 66 313
2025-02-07 2025-02-05 4 Goldan Keith A. SNDX Common Stock A - Award D 23 400 94 523
2025-02-07 2025-02-05 4 Goldan Keith A. SNDX Common Stock A - Award D 18 500 71 123
2025-02-07 2025-02-05 4 Metzger Michael A SNDX Common Stock A - Award D 89 000 313 409
2025-02-07 2025-02-05 4 Metzger Michael A SNDX Common Stock A - Award D 60 500 224 409
2025-02-07 2025-02-05 4 Podlesak Dennis SNDX Common Stock A - Award D 50 000 191 763
2025-02-07 2025-02-05 4 Rizo Aleksandra SNDX Common Stock A - Award D 25 000 25 000
2025-02-07 2025-02-05 4 Meury William SNDX Common Stock A - Award D 25 000 90 000
2025-02-07 2025-02-05 4 Katkin Keith SNDX Common Stock A - Award D 25 000 90 000
2025-02-07 2025-02-05 4 Jarrett Jennifer SNDX Common Stock A - Award D 25 000 90 000
2025-02-07 2025-02-05 4 Huber Martin H. Jr. SNDX Common Stock A - Award D 25 000 74 000
2025-02-07 2025-02-05 4 Legault Pierre SNDX Common Stock A - Award D 25 000 90 000
2024-06-17 2024-06-14 4 Goldan Keith A. SNDX Common Stock P - Purchase D 20,0298 1 250 25 52 623
2024-02-09 2024-02-07 4 Katkin Keith SNDX Common Stock A - Award D 17 000 65 000
2024-02-09 2024-02-07 4 Jarrett Jennifer SNDX Common Stock A - Award D 17 000 65 000
2024-02-09 2024-02-07 4 Metzger Michael A SNDX Common Stock A - Award D 39 000 163 909
2024-02-09 2024-02-07 4 Metzger Michael A SNDX Common Stock A - Award D 107 250 124 909
2024-02-09 2024-02-07 4 Huber Martin H. Jr. SNDX Common Stock A - Award D 17 000 49 000
2024-02-09 2024-02-07 4 Gallagher Neil SNDX Common Stock A - Award D 13 125 47 813
2024-02-09 2024-02-07 4 Gallagher Neil SNDX Common Stock A - Award D 34 688 34 688
2024-02-09 2024-02-07 4 Goldan Keith A. SNDX Common Stock A - Award D 11 700 51 373
2024-02-09 2024-02-07 4 Goldan Keith A. SNDX Common Stock A - Award D 35 000 39 673
2024-02-09 2024-01-31 4 Goldan Keith A. SNDX Common Stock J - Other D 17,4200 1 183 21 4 673
2024-02-09 2023-07-31 4 Goldan Keith A. SNDX Common Stock J - Other D 18,1200 862 16 3 490
2024-02-09 2024-02-07 4 Legault Pierre SNDX Common Stock A - Award D 17 000 65 000
2024-02-09 2024-02-07 4 Podlesak Dennis SNDX Common Stock A - Award D 34 000 141 763
2024-02-09 2024-02-07 4 Morrison Briggs SNDX Common Stock A - Award D 17 000 34 836
2024-02-09 2024-02-07 4 Meury William SNDX Common Stock A - Award D 17 000 65 000
2023-08-10 2023-08-09 4 Morrison Briggs SNDX Common Stock S - Sale D 18,2651 −52 855 −965 17 836
2023-08-10 2023-08-09 4 Morrison Briggs SNDX Common Stock M - Exercise D 8,7700 52 855 464 70 691
2023-08-03 2023-08-02 4 Meury William SNDX Common Stock S - Sale D 20,4547 −24 000 −491 48 000
2023-08-03 2023-08-02 4 Meury William SNDX Common Stock M - Exercise D 9,4700 24 000 227 72 000
2023-08-03 2023-08-02 4 Meury William SNDX Common Stock S - Sale D 20,4563 −24 000 −491 48 000
2023-08-03 2023-08-02 4 Meury William SNDX Common Stock M - Exercise D 7,8800 24 000 189 72 000
2023-08-03 2023-08-02 4 Meury William SNDX Common Stock S - Sale D 20,4556 −35 000 −716 48 000
2023-08-03 2023-08-02 4 Meury William SNDX Common Stock M - Exercise D 7,1100 35 000 249 83 000
2023-07-11 2023-07-10 4 Morrison Briggs SNDX Common Stock S - Sale D 20,3967 −52 855 −1 078 17 836
2023-07-11 2023-07-10 4 Morrison Briggs SNDX Common Stock M - Exercise D 8,7700 52 855 464 70 691
2023-06-14 2023-06-13 4 Goldan Keith A. SNDX Common Stock S - Sale D 22,3100 −577 −13 2 628
2023-06-09 2023-06-09 4 Morrison Briggs SNDX Common Stock S - Sale D 21,1791 −28 273 −599 17 836
2023-06-09 2023-06-09 4 Morrison Briggs SNDX Common Stock S - Sale D 21,1791 −24 582 −521 46 109
2023-06-09 2023-06-09 4 Morrison Briggs SNDX Common Stock M - Exercise D 8,7700 28 273 248 70 691
2023-06-09 2023-06-09 4 Morrison Briggs SNDX Common Stock M - Exercise D 6,3800 24 582 157 42 418
2023-05-10 2023-05-09 4 Morrison Briggs SNDX Common Stock S - Sale D 21,4072 −52 855 −1 131 17 836
2023-05-10 2023-05-09 4 Morrison Briggs SNDX Common Stock M - Exercise D 6,3800 52 855 337 70 691
2023-04-12 2023-04-10 4 Morrison Briggs SNDX Common Stock S - Sale D 19,5296 −52 855 −1 032 17 836
2023-04-12 2023-04-10 4 Morrison Briggs SNDX Common Stock M - Exercise D 6,3800 52 855 337 70 691
2023-03-14 2023-03-13 4 Morrison Briggs SNDX Common Stock S - Sale D 22,5276 −52 854 −1 191 17 836
2023-03-14 2023-03-13 4 Morrison Briggs SNDX Common Stock M - Exercise D 6,3800 52 854 337 70 690
2023-02-17 2023-02-15 4 Ordentlich Peter SNDX Common Stock S - Sale D 25,8437 −17 428 −450 0
2023-02-17 2023-02-15 4 Ordentlich Peter SNDX Common Stock M - Exercise D 7,2000 17 428 125 17 428
2023-02-17 2023-02-15 4 Ordentlich Peter SNDX Common Stock S - Sale D 25,8437 −7 572 −196 0
2023-02-17 2023-02-15 4 Ordentlich Peter SNDX Common Stock M - Exercise D 6,3800 7 572 48 7 572
2023-02-08 2023-02-06 4 Morrison Briggs SNDX Common Stock S - Sale D 26,8269 −52 854 −1 418 17 836
2023-02-08 2023-02-06 4 Morrison Briggs SNDX Common Stock M - Exercise D 6,3800 52 854 337 70 690
2023-02-08 2023-02-06 4 Metzger Michael A SNDX Common Stock S - Sale D 27,6384 −5 959 −165 17 659
2023-02-08 2023-02-06 4 Metzger Michael A SNDX Common Stock M - Exercise D 6,3800 5 959 38 23 618
2023-02-03 2023-02-02 4 Podlesak Dennis SNDX Common Stock A - Award D 32 000 107 763
2023-02-03 2023-02-01 4 Ordentlich Peter SNDX Common Stock S - Sale D 28,4281 −69 −2 0
2023-02-03 2023-01-31 4 Ordentlich Peter SNDX Common Stock J - Other D 17,3200 69 1 69
2023-02-03 2023-02-02 4 Meury William SNDX Common Stock A - Award D 16 000 48 000
2023-02-03 2023-02-02 4 Huber Martin H. Jr. SNDX Common Stock A - Award D 16 000 32 000
2023-02-03 2023-02-02 4 Legault Pierre SNDX Common Stock A - Award D 16 000 48 000
2023-02-03 2023-02-02 4 Katkin Keith SNDX Common Stock A - Award D 16 000 48 000
2023-02-03 2023-02-02 4 Jarrett Jennifer SNDX Common Stock A - Award D 16 000 48 000
2023-01-13 2023-01-13 4 Legault Pierre SNDX Common Stock S - Sale D 27,0000 −5 000 −135 32 000
2023-01-13 2023-01-13 4 Legault Pierre SNDX Common Stock M - Exercise D 13,5800 5 000 68 37 000
2023-01-13 2023-01-13 4 Legault Pierre SNDX Common Stock S - Sale D 27,0000 −10 000 −270 32 000
2023-01-13 2023-01-13 4 Legault Pierre SNDX Common Stock M - Exercise D 13,5800 10 000 136 42 000
2023-01-13 2023-01-12 4 Legault Pierre SNDX Common Stock S - Sale D 26,7409 −24 000 −642 32 000
2023-01-13 2023-01-12 4 Legault Pierre SNDX Common Stock M - Exercise D 9,4700 24 000 227 56 000
2022-12-02 2022-12-02 4 Ordentlich Peter SNDX Common Stock S - Sale D 25,0544 −17 200 −431 265
2022-12-02 2022-12-02 4 Ordentlich Peter SNDX Common Stock M - Exercise D 6,3800 17 200 110 17 465
2022-12-02 2022-12-01 4 Ordentlich Peter SNDX Common Stock S - Sale D 25,0114 −4 028 −101 265
2022-12-02 2022-12-01 4 Ordentlich Peter SNDX Common Stock M - Exercise D 6,3800 4 028 26 4 293
2022-12-02 2022-12-01 4 Ordentlich Peter SNDX Common Stock S - Sale D 25,0114 −3 772 −94 265
2022-12-02 2022-12-01 4 Ordentlich Peter SNDX Common Stock M - Exercise D 6,3500 3 772 24 4 037
2022-10-07 2022-10-06 4 Katkin Keith SNDX Common Stock S - Sale D 25,9009 −9 117 −236 32 000
2022-10-07 2022-10-06 4 Katkin Keith SNDX Common Stock M - Exercise D 8,9300 9 117 81 41 117
2022-10-07 2022-10-06 4 Katkin Keith SNDX Common Stock S - Sale D 25,9009 −20 782 −538 32 000
2022-10-07 2022-10-06 4 Katkin Keith SNDX Common Stock M - Exercise D 7,8800 20 782 164 52 782
2022-10-07 2022-10-06 4 Metzger Michael A SNDX Common Stock S - Sale D 25,2916 −16 231 −411 17 659
2022-10-07 2022-10-06 4 Metzger Michael A SNDX Common Stock M - Exercise D 8,7700 16 231 142 33 890
2022-10-04 2022-10-04 4 Metzger Michael A SNDX Common Stock S - Sale D 25,0206 −1 280 −32 17 659
2022-10-04 2022-10-04 4 Metzger Michael A SNDX Common Stock M - Exercise D 8,7700 1 280 11 18 939
2022-10-04 2022-10-03 4 Metzger Michael A SNDX Common Stock S - Sale D 25,0110 −2 883 −72 17 659
2022-10-04 2022-10-03 4 Metzger Michael A SNDX Common Stock M - Exercise D 8,7700 2 883 25 20 542
2022-10-04 2022-09-30 4 Metzger Michael A SNDX Common Stock S - Sale D 25,0205 −29 606 −741 17 659
2022-10-04 2022-09-30 4 Metzger Michael A SNDX Common Stock M - Exercise D 8,7700 29 606 260 47 265
2022-10-04 2022-10-04 4 Katkin Keith SNDX Common Stock S - Sale D 25,0000 −223 −6 32 000
2022-10-04 2022-10-04 4 Katkin Keith SNDX Common Stock M - Exercise D 8,9300 223 2 32 223
2022-10-04 2022-10-04 4 Katkin Keith SNDX Common Stock S - Sale D 25,0000 −137 −3 32 000
2022-10-04 2022-10-04 4 Katkin Keith SNDX Common Stock M - Exercise D 7,8800 137 1 32 137
2022-10-04 2022-10-03 4 Katkin Keith SNDX Common Stock S - Sale D 25,0000 −13 −0 32 000
2022-10-04 2022-10-03 4 Katkin Keith SNDX Common Stock M - Exercise D 8,9300 13 0 32 013
2022-10-04 2022-10-03 4 Katkin Keith SNDX Common Stock S - Sale D 25,0000 −167 −4 32 000
2022-10-04 2022-10-03 4 Katkin Keith SNDX Common Stock M - Exercise D 7,8800 167 1 32 167
2022-10-04 2022-09-30 4 Katkin Keith SNDX Common Stock S - Sale D 25,0707 −647 −16 32 000
2022-10-04 2022-09-30 4 Katkin Keith SNDX Common Stock M - Exercise D 8,9300 647 6 32 647
2022-10-04 2022-09-30 4 Katkin Keith SNDX Common Stock S - Sale D 25,0707 −2 914 −73 32 000
2022-10-04 2022-09-30 4 Katkin Keith SNDX Common Stock M - Exercise D 7,8800 2 914 23 34 914
2022-09-21 2022-09-20 4 Morrison Briggs SNDX Common Stock S - Sale D 23,2529 −59 649 −1 387 17 836
2022-09-21 2022-09-20 4 Morrison Briggs SNDX Common Stock M - Exercise D 10,9000 59 649 650 77 485
2022-09-21 2022-09-19 4 Morrison Briggs SNDX Common Stock S - Sale D 23,0284 −114 339 −2 633 17 836
2022-09-21 2022-09-19 4 Morrison Briggs SNDX Common Stock M - Exercise D 10,9000 114 339 1 246 132 175
2022-09-16 2022-09-16 4 Podlesak Dennis SNDX Common Stock S - Sale D 23,4327 −6 556 −154 75 763
2022-09-16 2022-09-16 4 Podlesak Dennis SNDX Common Stock M - Exercise D 6,3500 6 556 42 82 319
2022-09-16 2022-09-16 4 Podlesak Dennis SNDX Common Stock S - Sale D 23,4327 −5 419 −127 75 763
2022-09-16 2022-09-16 4 Podlesak Dennis SNDX Common Stock M - Exercise D 6,3200 5 419 34 81 182
2022-09-16 2022-09-15 4 Podlesak Dennis SNDX Common Stock S - Sale D 24,1978 −66 840 −1 617 75 763
2022-09-16 2022-09-15 4 Podlesak Dennis SNDX Common Stock M - Exercise D 6,3200 66 840 422 142 603
2022-09-16 2022-09-16 4 Morrison Briggs SNDX Common Stock S - Sale D 23,2195 −53 034 −1 231 17 836
2022-09-16 2022-09-16 4 Morrison Briggs SNDX Common Stock M - Exercise D 10,9000 53 034 578 70 870
2022-09-16 2022-09-16 4 Morrison Briggs SNDX Common Stock S - Sale D 23,2195 −71 966 −1 671 17 836
2022-09-16 2022-09-16 4 Morrison Briggs SNDX Common Stock M - Exercise D 7,2000 71 966 518 89 802
2022-09-16 2022-09-15 4 Morrison Briggs SNDX Common Stock S - Sale D 24,2012 −66 775 −1 616 17 836
2022-09-16 2022-09-15 4 Morrison Briggs SNDX Common Stock M - Exercise D 7,2000 66 775 481 84 611
2022-09-16 2022-09-14 4 Morrison Briggs SNDX Common Stock S - Sale D 23,7989 −87 645 −2 086 17 836
2022-09-16 2022-09-14 4 Morrison Briggs SNDX Common Stock M - Exercise D 7,2000 87 645 631 105 481
2022-08-26 2022-08-24 4 Ordentlich Peter SNDX Common Stock S - Sale D 25,0357 −2 154 −54 265
2022-08-26 2022-08-24 4 Ordentlich Peter SNDX Common Stock M - Exercise D 6,3500 2 154 14 2 419
2022-08-26 2022-08-24 4 Ordentlich Peter SNDX Common Stock S - Sale D 25,0357 −22 846 −572 265
2022-08-26 2022-08-24 4 Ordentlich Peter SNDX Common Stock M - Exercise D 6,3200 22 846 144 23 111
2022-08-26 2022-07-29 4 Ordentlich Peter SNDX Common Stock J - Other D 14,1200 265 4 265
2022-08-09 2022-08-05 4 Legault Pierre SNDX Common Stock S - Sale D 23,0159 −14 000 −322 32 000
2022-08-09 2022-08-05 4 Legault Pierre SNDX Common Stock M - Exercise D 8,9300 14 000 125 46 000
2022-08-09 2022-08-05 4 Legault Pierre SNDX Common Stock S - Sale D 23,0159 −10 000 −230 32 000
2022-08-09 2022-08-05 4 Legault Pierre SNDX Common Stock M - Exercise D 9,6300 10 000 96 42 000
2022-07-27 2022-07-25 4 Metzger Michael A SNDX Common Stock S - Sale D 21,0554 −11 838 −249 17 659
2022-07-27 2022-07-25 4 Metzger Michael A SNDX Common Stock M - Exercise D 6,3800 11 838 76 29 497
2022-07-27 2022-07-25 4 Metzger Michael A SNDX Common Stock S - Sale D 21,0554 −19 764 −416 17 659
2022-07-27 2022-07-25 4 Metzger Michael A SNDX Common Stock M - Exercise D 6,3800 19 764 126 37 423
2022-07-08 2022-07-07 4 Metzger Michael A SNDX Common Stock S - Sale D 21,0000 −100 −2 17 659
2022-07-08 2022-07-07 4 Metzger Michael A SNDX Common Stock M - Exercise D 6,3800 100 1 17 759
2022-07-08 2022-07-06 4 Metzger Michael A SNDX Common Stock S - Sale D 21,0745 −15 009 −316 17 659
2022-07-08 2022-07-06 4 Metzger Michael A SNDX Common Stock M - Exercise D 6,3800 15 009 96 32 668
2022-07-05 2022-07-01 4 Morrison Briggs SNDX Common Stock S - Sale D 18,9981 −62 292 −1 183 17 836
2022-07-05 2022-07-01 4 Morrison Briggs SNDX Common Stock M - Exercise D 7,2000 62 292 449 80 128
2022-06-15 2022-06-13 4 Goldan Keith A. SNDX Common Stock A - Award D 3 205 3 205
2022-04-13 2022-04-04 4/A Morrison Briggs SNDX Stock Options (Right to buy) M - Exercise D 7,20 −3 128 0
2022-04-13 2022-04-04 4/A Morrison Briggs SNDX Common Stock M - Exercise D 7,2000 3 128 23 20 964
2022-04-13 2022-04-01 4/A Morrison Briggs SNDX Stock Options (Right to buy) M - Exercise D 7,20 −70 545 0
2022-04-13 2022-04-01 4/A Morrison Briggs SNDX Common Stock M - Exercise D 7,2000 70 545 508 88 381
2022-04-05 2022-04-04 4 Morrison Briggs SNDX Stock Options (Right to buy) M - Exercise D 10,90 −3 128 0
2022-04-05 2022-04-04 4 Morrison Briggs SNDX Common Stock S - Sale D 18,2928 −3 128 −57 17 836
2022-04-05 2022-04-04 4 Morrison Briggs SNDX Common Stock M - Exercise D 10,9000 3 128 34 20 964
2022-04-05 2022-04-01 4 Morrison Briggs SNDX Stock Options (Right to buy) M - Exercise D 10,90 −70 545 0
2022-04-05 2022-04-01 4 Morrison Briggs SNDX Common Stock S - Sale D 17,4579 −70 545 −1 232 17 836
2022-04-05 2022-04-01 4 Morrison Briggs SNDX Common Stock M - Exercise D 10,9000 70 545 769 88 381
2022-04-05 2022-04-01 4 Morrison Briggs SNDX Common Stock S - Sale D 17,4414 −24 500 −427 17 836
2022-04-05 2022-04-01 4 Morrison Briggs SNDX Common Stock S - Sale D 17,4389 −6 000 −105 42 336
2022-03-03 2022-03-01 4 Madigan Catherine SNDX Stock Options (Right to buy) A - Award D 16,06 16,0600 180 000 2 891 180 000
2022-02-03 2022-02-02 4 Metzger Michael A SNDX Stock Options (Right to buy) A - Award D 15,79 15,7900 325 000 5 132 325 000
2022-02-03 2022-02-02 4 Meyers Michael L. SNDX Stock Options (Right to buy) A - Award D 15,79 15,7900 17 350 274 17 350
2022-02-03 2022-01-31 4 Meyers Michael L. SNDX Common Stock J - Other D 12,3900 1 714 21 23 280
2022-02-03 2022-02-02 4 Ordentlich Peter SNDX Stock Options (Right to buy) A - Award D 15,79 15,7900 80 000 1 263 80 000
2022-02-03 2022-02-01 4 Ordentlich Peter SNDX Common Stock S - Sale D 16,6500 −1 412 −24 0
2022-02-03 2022-01-31 4 Ordentlich Peter SNDX Common Stock J - Other D 12,3900 1 412 17 1 412
2022-02-03 2022-02-02 4 Morrison Briggs SNDX Stock Options (Right to buy) A - Award D 15,79 15,7900 160 000 2 526 160 000
2022-02-03 2022-02-02 4 Katkin Keith SNDX Common Stock A - Award D 16 000 32 000
2022-02-03 2022-02-02 4 Podlesak Dennis SNDX Common Stock A - Award D 32 000 75 763
2022-02-03 2022-02-02 4 Nolte Alexander SNDX Stock Options (Right to buy) A - Award D 15,79 15,7900 30 000 474 30 000
2022-02-03 2022-02-01 4 Nolte Alexander SNDX Common Stock S - Sale D 16,6500 −968 −16 0
2022-02-03 2022-01-31 4 Nolte Alexander SNDX Common Stock J - Other D 12,3900 968 12 968
2022-02-03 2022-02-02 4 Legault Pierre SNDX Common Stock A - Award D 16 000 32 000
2022-02-03 2022-02-02 4 Egros Fabrice SNDX Common Stock A - Award D 16 000 32 000
2022-02-03 2022-02-02 4 Jarrett Jennifer SNDX Common Stock A - Award D 16 000 32 000
2022-02-03 2022-02-02 4 Meury William SNDX Common Stock A - Award D 16 000 32 000
2022-02-03 2022-02-02 4 Huber Martin H. Jr. SNDX Common Stock A - Award D 16 000 16 000
2022-01-03 2021-12-30 4 Meyers Michael L. SNDX Stock Options (Right to buy) M - Exercise D 8,77 −5 900 0
2022-01-03 2021-12-30 4 Meyers Michael L. SNDX Common Stock M - Exercise D 8,7700 5 900 52 21 566
2021-12-22 2021-12-22 4 Legault Pierre SNDX Stock Options (Right to buy) M - Exercise D 7,88 −24 000 0
2021-12-22 2021-12-22 4 Legault Pierre SNDX Common Stock S - Sale D 22,0086 −24 000 −528 16 000
2021-12-22 2021-12-22 4 Legault Pierre SNDX Common Stock M - Exercise D 7,8800 24 000 189 40 000
2021-12-22 2021-12-20 4 Legault Pierre SNDX Stock Options (Right to buy) M - Exercise D 7,08 −20 000 0
2021-12-22 2021-12-20 4 Legault Pierre SNDX Common Stock S - Sale D 21,0125 −20 000 −420 16 000
2021-12-22 2021-12-20 4 Legault Pierre SNDX Common Stock M - Exercise D 7,0800 20 000 142 36 000
2021-12-20 2021-12-20 4 Metzger Michael A SNDX Stock Options (Right to buy) M - Exercise D 6,38 −16 000 0
2021-12-20 2021-12-20 4 Metzger Michael A SNDX Stock Options (Right to buy) M - Exercise D 8,77 −45 000 0
2021-12-20 2021-12-20 4 Metzger Michael A SNDX Common Stock S - Sale D 20,2880 −45 000 −913 17 659
2021-12-20 2021-12-20 4 Metzger Michael A SNDX Common Stock M - Exercise D 8,7700 45 000 395 62 659
2021-12-20 2021-12-20 4 Metzger Michael A SNDX Common Stock S - Sale D 20,2880 −16 000 −325 17 659
2021-12-20 2021-12-20 4 Metzger Michael A SNDX Common Stock M - Exercise D 6,3800 16 000 102 33 659
2021-12-20 2021-12-17 4 Metzger Michael A SNDX Stock Options (Right to buy) M - Exercise D 6,38 −1 676 0
2021-12-20 2021-12-17 4 Metzger Michael A SNDX Common Stock S - Sale D 19,0198 −1 676 −32 17 659
2021-12-20 2021-12-17 4 Metzger Michael A SNDX Common Stock M - Exercise D 6,3800 1 676 11 19 335
2021-12-20 2021-12-16 4 Metzger Michael A SNDX Stock Options (Right to buy) M - Exercise D 6,38 −22 715 0
2021-12-20 2021-12-16 4 Metzger Michael A SNDX Common Stock S - Sale D 19,0799 −22 715 −433 17 659
2021-12-20 2021-12-16 4 Metzger Michael A SNDX Common Stock M - Exercise D 6,3800 22 715 145 40 374
2021-12-20 2021-12-17 4 Morrison Briggs SNDX Stock Options (Right to buy) M - Exercise D 10,90 −35 156 0
2021-12-20 2021-12-17 4 Morrison Briggs SNDX Common Stock S - Sale D 20,0000 −35 156 −703 48 336
2021-12-20 2021-12-17 4 Morrison Briggs SNDX Common Stock M - Exercise D 10,9000 35 156 383 83 492
2021-12-15 2021-12-13 4 Metzger Michael A SNDX Stock Options (Right to buy) M - Exercise D 6,38 −34 564 0
2021-12-15 2021-12-13 4 Metzger Michael A SNDX Stock Options (Right to buy) M - Exercise D 7,20 −2 045 0
2021-12-15 2021-12-13 4 Metzger Michael A SNDX Common Stock S - Sale D 19,0532 −34 564 −659 17 659
2021-12-15 2021-12-13 4 Metzger Michael A SNDX Common Stock M - Exercise D 6,3800 34 564 221 52 223
2021-12-15 2021-12-13 4 Metzger Michael A SNDX Common Stock S - Sale D 19,0532 −2 045 −39 17 659
2021-12-15 2021-12-13 4 Metzger Michael A SNDX Common Stock M - Exercise D 7,2000 2 045 15 19 704
2021-11-19 2021-11-18 4 Egros Fabrice SNDX Stock Options (Right to buy) M - Exercise D 7,88 −30 0
2021-11-19 2021-11-18 4 Egros Fabrice SNDX Stock Options (Right to buy) M - Exercise D 8,93 −14 000 0
2021-11-19 2021-11-18 4 Egros Fabrice SNDX Common Stock S - Sale D 18,0323 −30 −1 16 000
2021-11-19 2021-11-18 4 Egros Fabrice SNDX Common Stock M - Exercise D 7,8800 30 0 16 030
2021-11-19 2021-11-18 4 Egros Fabrice SNDX Common Stock S - Sale D 18,0323 −14 000 −252 16 000
2021-11-19 2021-11-18 4 Egros Fabrice SNDX Common Stock M - Exercise D 8,9300 14 000 125 30 000
2021-10-27 2021-10-26 4 Metzger Michael A SNDX Stock Options (Right to buy) M - Exercise D 7,20 −16 296 0
2021-10-27 2021-10-26 4 Metzger Michael A SNDX Common Stock S - Sale D 19,1964 −16 296 −313 17 659
2021-10-27 2021-10-26 4 Metzger Michael A SNDX Common Stock M - Exercise D 7,2000 16 296 117 33 955
2021-10-27 2021-10-25 4 Metzger Michael A SNDX Stock Options (Right to buy) M - Exercise D 7,20 −44 704 0
2021-10-27 2021-10-25 4 Metzger Michael A SNDX Common Stock S - Sale D 19,1333 −44 704 −855 17 659
2021-10-27 2021-10-25 4 Metzger Michael A SNDX Common Stock M - Exercise D 7,2000 44 704 322 62 363
2021-10-06 2021-10-05 4 Podlesak Dennis SNDX Common Stock J - Other D 463 43 763
2021-09-28 2021-09-27 4 Metzger Michael A SNDX Stock Options (Right to buy) M - Exercise D 7,20 −24 437 0
2021-09-28 2021-09-27 4 Metzger Michael A SNDX Common Stock S - Sale D 19,5127 −24 437 −477 17 659
2021-09-28 2021-09-27 4 Metzger Michael A SNDX Common Stock M - Exercise D 7,2000 24 437 176 42 096
2021-09-22 2021-09-22 4 Metzger Michael A SNDX Stock Options (Right to buy) M - Exercise D 7,20 −300 0
2021-09-22 2021-09-22 4 Metzger Michael A SNDX Common Stock S - Sale D 19,0200 −300 −6 17 659
2021-09-22 2021-09-22 4 Metzger Michael A SNDX Common Stock M - Exercise D 7,2000 300 2 17 959
2021-09-22 2021-09-21 4 Metzger Michael A SNDX Stock Options (Right to buy) M - Exercise D 7,20 −4 808 0
2021-09-22 2021-09-21 4 Metzger Michael A SNDX Common Stock S - Sale D 19,1573 −4 808 −92 17 659
2021-09-22 2021-09-21 4 Metzger Michael A SNDX Common Stock M - Exercise D 7,2000 4 808 35 22 467
2021-09-22 2021-09-20 4 Metzger Michael A SNDX Stock Options (Right to buy) M - Exercise D 7,20 −31 455 0
2021-09-22 2021-09-20 4 Metzger Michael A SNDX Common Stock S - Sale D 19,2353 −31 455 −605 17 659
2021-09-22 2021-09-20 4 Metzger Michael A SNDX Common Stock M - Exercise D 7,2000 31 455 226 49 114
2021-09-21 2021-09-20 4 Morrison Briggs SNDX Stock Options (Right to buy) M - Exercise D 7,20 −50 0
2021-09-21 2021-09-20 4 Morrison Briggs SNDX Common Stock S - Sale D 20,0000 −50 −1 48 336
2021-09-21 2021-09-20 4 Morrison Briggs SNDX Common Stock M - Exercise D 7,2000 50 0 48 386
2021-09-21 2021-09-17 4 Morrison Briggs SNDX Stock Options (Right to buy) M - Exercise D 7,20 −70 262 0
2021-09-21 2021-09-17 4 Morrison Briggs SNDX Common Stock S - Sale D 20,0680 −70 262 −1 410 48 336
2021-09-21 2021-09-17 4 Morrison Briggs SNDX Common Stock M - Exercise D 7,2000 70 262 506 118 598
2021-09-17 2021-09-15 4 Huber Martin H. Jr. SNDX Stock Options (Right to buy) A - Award D 19,36 19,3600 35 000 678 35 000
2021-09-15 2021-09-14 4 Metzger Michael A SNDX Stock Options (Right to buy) M - Exercise D 7,20 −44 349 0
2021-09-15 2021-09-14 4 Metzger Michael A SNDX Common Stock S - Sale D 19,1525 −44 349 −849 17 659
2021-09-15 2021-09-14 4 Metzger Michael A SNDX Common Stock M - Exercise D 7,2000 44 349 319 62 008
2021-09-15 2021-09-13 4 Metzger Michael A SNDX Stock Options (Right to buy) M - Exercise D 7,20 −16 651 0
2021-09-15 2021-09-13 4 Metzger Michael A SNDX Common Stock S - Sale D 19,0162 −16 651 −317 17 659
2021-09-15 2021-09-13 4 Metzger Michael A SNDX Common Stock M - Exercise D 7,2000 16 651 120 34 310
2021-08-20 2021-08-18 4 Egros Fabrice SNDX Stock Options (Right to buy) M - Exercise D 7,88 −15 635 0
2021-08-20 2021-08-18 4 Egros Fabrice SNDX Common Stock S - Sale D 15,7549 −15 635 −246 16 000
2021-08-20 2021-08-18 4 Egros Fabrice SNDX Common Stock M - Exercise D 7,8800 15 635 123 31 635
2021-05-20 2021-05-18 4 Egros Fabrice SNDX Stock Options (Right to buy) M - Exercise D 7,20 −11 926 0
2021-05-20 2021-05-18 4 Egros Fabrice SNDX Stock Options (Right to buy) M - Exercise D 7,88 −1 683 0
2021-05-20 2021-05-18 4 Egros Fabrice SNDX Common Stock S - Sale D 18,6482 −1 683 −31 16 000
2021-05-20 2021-05-18 4 Egros Fabrice SNDX Common Stock S - Sale D 18,6482 −11 926 −222 17 683
2021-05-20 2021-05-18 4 Egros Fabrice SNDX Common Stock M - Exercise D 7,8800 1 683 13 29 609
2021-05-20 2021-05-18 4 Egros Fabrice SNDX Common Stock M - Exercise D 7,2000 11 926 86 27 926
2021-04-28 2021-04-26 4 Meyers Michael L. SNDX Common Stock P - Purchase D 15,4600 500 8 15 666
2021-04-22 2021-04-22 4 Podlesak Dennis SNDX Common Stock P - Purchase D 14,1102 13 967 197 43 300
2021-03-03 2021-03-01 4 Egros Fabrice SNDX Stock Options (Right to buy) M - Exercise D 6,35 −10 167 0
2021-03-03 2021-03-01 4 Egros Fabrice SNDX Stock Options (Right to buy) M - Exercise D 7,20 −74 0
2021-03-03 2021-03-01 4 Egros Fabrice SNDX Common Stock S - Sale D 24,3122 −74 −2 16 000
2021-03-03 2021-03-01 4 Egros Fabrice SNDX Common Stock S - Sale D 24,3122 −10 167 −247 16 074
2021-03-03 2021-03-01 4 Egros Fabrice SNDX Common Stock M - Exercise D 7,2000 74 1 26 241
2021-03-03 2021-03-01 4 Egros Fabrice SNDX Common Stock M - Exercise D 6,3500 10 167 65 26 167
2021-02-10 2021-02-08 4 Morrison Briggs SNDX Stock Options (Right to buy) M - Exercise D 7,20 −35 156 0
2021-02-10 2021-02-08 4 Morrison Briggs SNDX Common Stock S - Sale D 20,5485 −35 156 −722 48 336
2021-02-10 2021-02-08 4 Morrison Briggs SNDX Common Stock M - Exercise D 7,2000 35 156 253 83 492
2021-02-05 2021-02-03 4 Morrison Briggs SNDX Stock Option (Right to Buy) A - Award D 21,36 195 000 195 000
2021-02-05 2021-01-31 4 Morrison Briggs SNDX Common Stock J - Other D 12,0000 1 771 21 48 336
2021-02-05 2021-02-03 4 Karydas Daphne SNDX Stock Option (Right to Buy) A - Award D 21,36 95 000 95 000
2021-02-05 2021-02-03 4 Ordentlich Peter SNDX Stock Option (Right to Buy) A - Award D 21,36 80 000 80 000
2021-02-05 2021-02-03 4 Metzger Michael A SNDX Stock Option (Right to Buy) A - Award D 21,36 160 000 160 000
2021-02-05 2021-02-03 4 Podlesak Dennis SNDX Common Stock A - Award D 29 333 29 333
2021-02-05 2021-02-03 4 Meyers Michael L. SNDX Stock Option (Right to Buy) A - Award D 21,36 80 000 80 000
2021-02-05 2021-01-31 4 Meyers Michael L. SNDX Common Stock J - Other D 12,0000 1 771 21 15 166
2021-02-05 2020-07-31 4 Meyers Michael L. SNDX Common Stock J - Other D 7,9700 2 665 21 13 395
2021-02-05 2021-02-03 4 Jarrett Jennifer SNDX Common Stock A - Award D 16 000 16 000
2021-02-05 2021-02-03 4 Katkin Keith SNDX Common Stock A - Award D 16 000 16 000
2021-02-05 2021-02-03 4 Meury William SNDX Common Stock A - Award D 16 000 16 000
2021-02-05 2021-02-03 4 Egros Fabrice SNDX Common Stock A - Award D 16 000 16 000
2021-02-05 2021-02-03 4 Legault Pierre SNDX Common Stock A - Award D 16 000 16 000
2021-02-03 2021-02-01 4 Metzger Michael A SNDX Stock Options (Right to buy) M - Exercise D 7,20 −15 000 0
2021-02-03 2021-02-01 4 Metzger Michael A SNDX Common Stock S - Sale D 20,1866 −15 000 −303 17 659
2021-02-03 2021-02-01 4 Metzger Michael A SNDX Common Stock M - Exercise D 7,2000 15 000 108 32 659
2020-12-03 2020-12-01 4 Metzger Michael A SNDX Employee Stock Option (right to buy) M - Exercise D 7,20 −15 000 0
2020-12-03 2020-12-01 4 Metzger Michael A SNDX Common Stock S - Sale D 22,9675 −15 000 −345 17 659
2020-12-03 2020-12-01 4 Metzger Michael A SNDX Common Stock M - Exercise D 7,2000 15 000 108 32 659
2020-11-25 2020-11-23 4 Ordentlich Peter SNDX Stock Option (Right to Buy) M - Exercise D 3,08 −5 684 0
2020-11-25 2020-11-23 4 Ordentlich Peter SNDX Stock Option (Right to Buy) M - Exercise D 3,08 −24 288 0
2020-11-25 2020-11-23 4 Ordentlich Peter SNDX Common Stock S - Sale D 22,8924 −16 334 −374 0
2020-11-25 2020-11-23 4 Ordentlich Peter SNDX Common Stock S - Sale D 23,5849 −7 954 −188 16 334
2020-11-25 2020-11-23 4 Ordentlich Peter SNDX Common Stock S - Sale D 23,3291 −5 684 −133 24 288
2020-11-25 2020-11-23 4 Ordentlich Peter SNDX Common Stock M - Exercise D 3,0800 5 684 18 29 972
2020-11-25 2020-11-23 4 Ordentlich Peter SNDX Common Stock M - Exercise D 3,0800 24 288 75 24 288
2020-11-12 2020-11-10 4 Morrison Briggs SNDX Stock Options (Right to buy) M - Exercise D 7,20 −17 466 0
2020-11-12 2020-11-10 4 Morrison Briggs SNDX Common Stock S - Sale D 20,0568 −17 466 −350 46 565
2020-11-12 2020-11-10 4 Morrison Briggs SNDX Common Stock M - Exercise D 7,2000 17 466 126 64 031
2020-11-12 2020-11-09 4 Morrison Briggs SNDX Stock Options (Right to buy) M - Exercise D 7,20 −62 938 0
2020-11-12 2020-11-09 4 Morrison Briggs SNDX Common Stock S - Sale D 20,0398 −62 938 −1 261 46 565
2020-11-12 2020-11-09 4 Morrison Briggs SNDX Common Stock M - Exercise D 7,2000 62 938 453 109 503
2020-11-06 2020-11-04 4 Metzger Michael A SNDX Stock Options (Right to buy) M - Exercise D 7,20 −100 000 0
2020-11-06 2020-11-04 4 Metzger Michael A SNDX Common Stock S - Sale D 20,3141 −100 000 −2 031 17 659
2020-11-06 2020-11-04 4 Metzger Michael A SNDX Common Stock M - Exercise D 7,2000 100 000 720 117 659
2020-07-08 2020-07-06 4 Meyers Michael L. SNDX Common Stock A - Award D 3 500 10 730
2020-02-14 2020-02-12 4 Podlesak Dennis SNDX Stock Option (Right to Buy) A - Award D 9,47 44 000 44 000
2020-02-14 2020-02-12 4 Meury William SNDX Stock Option (Right to Buy) A - Award D 9,47 24 000 24 000
2020-02-14 2020-02-12 4 Legault Pierre SNDX Stock Option (Right to Buy) A - Award D 9,47 24 000 24 000
2020-02-14 2020-02-12 4 Jarrett Jennifer SNDX Stock Option (Right to Buy) A - Award D 9,47 24 000 24 000
2020-02-14 2020-02-12 4 Katkin Keith SNDX Stock Option (Right to Buy) A - Award D 9,47 24 000 24 000
2020-02-14 2020-02-12 4 Egros Fabrice SNDX Stock Option (Right to Buy) A - Award D 9,47 24 000 24 000
2020-02-14 2020-02-12 4 Ordentlich Peter SNDX Stock Option (Right to Buy) A - Award D 9,47 50 000 50 000
2020-02-14 2020-02-12 4 Morrison Briggs SNDX Stock Option (Right to Buy) A - Award D 9,47 194 000 194 000
2020-02-14 2020-02-12 4 Meyers Michael L. SNDX Stock Option (Right to Buy) A - Award D 9,47 50 825 50 825
2020-02-14 2020-02-12 4 Shea Richard P SNDX Stock Option (Right to Buy) A - Award D 9,47 43 200 43 200
2020-02-14 2020-01-31 4 Shea Richard P SNDX Common Stock J - Other D 7,9700 1 505 12 7 121
2020-02-14 2019-07-31 4 Shea Richard P SNDX Common Stock J - Other D 4,8900 1 401 7 5 616
2020-02-14 2020-02-12 4 Metzger Michael A SNDX Stock Option (Right to Buy) A - Award D 9,47 140 000 140 000
2020-02-14 2020-02-12 4 Metzger Michael A SNDX Common Stock A - Award D 15 000 17 659
2020-02-05 2020-02-04 4 Morrison Briggs SNDX Common Stock P - Purchase D 8,0000 12 500 100 43 900
2019-10-11 2019-10-10 4 Morrison Briggs SNDX Common Stock P - Purchase D 5,4000 11 000 59 31 400
2019-07-08 2019-07-04 4 Metzger Michael A SNDX Stock Option (Right to Buy) A - Award D 9,15 200 000 200 000
2019-06-12 2019-06-10 4 Egros Fabrice SNDX Stock Option (Right to Buy) A - Award D 7,88 24 000 24 000
2019-06-12 2019-06-10 4 Jarrett Jennifer SNDX Stock Option (Right to Buy) A - Award D 7,88 24 000 24 000
2019-06-12 2019-06-10 4 Katkin Keith SNDX Stock Option (Right to Buy) A - Award D 7,88 24 000 24 000
2019-06-12 2019-06-10 4 Legault Pierre SNDX Stock Option (Right to Buy) A - Award D 7,88 24 000 24 000
2019-06-12 2019-06-10 4 Meury William SNDX Stock Option (Right to Buy) A - Award D 7,88 24 000 24 000
2019-06-12 2019-06-10 4 Podlesak Dennis SNDX Stock Option (Right to Buy) A - Award D 7,88 44 000 44 000
2019-05-13 2019-05-13 4 Morrison Briggs SNDX Common Stock P - Purchase D 7,2940 7 200 53 20 400
2019-05-13 2019-05-09 4 Morrison Briggs SNDX Common Stock P - Purchase D 7,5550 13 200 100 13 200
2019-03-25 2019-03-21 4/A Meyers Michael L. SNDX Common Stock P - Purchase D 4,8700 8 0 7 230
2019-03-22 2019-03-21 4 Meyers Michael L. SNDX Common Stock P - Purchase D 4,8700 104 1 7 222
2019-03-22 2019-03-21 4 Meyers Michael L. SNDX Common Stock P - Purchase D 4,9300 1 000 5 7 118
2019-02-08 2019-02-06 4 Metzger Michael A SNDX Stock Option (Right to Buy) A - Award D 6,38 240 000 240 000
2019-02-08 2019-01-31 4 Metzger Michael A SNDX Common Stock J - Other D 4,7600 2 659 13 2 659
2019-02-08 2019-02-06 4 Meyers Michael L. SNDX Stock Option (Right to Buy) A - Award D 6,38 104 325 104 325
2019-02-08 2019-01-31 4 Meyers Michael L. SNDX Common Stock J - Other D 4,7600 3 720 18 6 118
2019-02-08 2019-02-06 4 Shea Richard P SNDX Stock Option (Right to Buy) A - Award D 6,38 91 200 91 200
2019-02-08 2019-01-31 4 Shea Richard P SNDX Common Stock J - Other D 4,7600 2 521 12 4 215
2019-02-08 2019-02-06 4 Morrison Briggs SNDX Stock Option (Right to Buy) A - Award D 6,38 354 000 354 000
2019-02-08 2019-02-06 4 Ordentlich Peter SNDX Stock Option (Right to Buy) A - Award D 6,38 80 000 80 000
2018-11-07 2018-10-30 4 Meyers Michael L. SNDX Common Stock P - Purchase D 4,7900 200 1 2 398
2018-09-27 2018-09-25 4 Meury William SNDX Stock Option (Right to Buy) A - Award D 7,11 35 000 35 000
2018-09-27 2018-09-25 4 Jarrett Jennifer SNDX Stock Option (Right to Buy) A - Award D 7,11 35 000 35 000
2018-06-20 2018-06-18 4 BVF PARTNERS L P/IL SNDX Warrants J - Other D 188 746 188 746
2018-06-20 2018-06-18 4 BVF PARTNERS L P/IL SNDX Warrants J - Other D 705 863 705 863
2018-06-20 2018-06-18 4 BVF PARTNERS L P/IL SNDX Warrants J - Other D 1 105 391 1 105 391
2018-06-20 2018-06-18 4 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share J - Other D −188 746 85 038
2018-06-20 2018-06-18 4 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share J - Other D −705 863 318 021
2018-06-20 2018-06-18 4 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share J - Other D −1 105 391 498 025
2018-05-25 2018-05-23 4 Chen Henry SNDX Stock Option (Right to Buy) A - Award D 8,93 14 000 14 000
2018-05-25 2018-05-23 4 Egros Fabrice SNDX Stock Option (Right to Buy) A - Award D 8,93 14 000 14 000
2018-05-25 2018-05-23 4 Katkin Keith SNDX Stock Option (Right to Buy) A - Award D 8,93 14 000 14 000
2018-05-25 2018-05-23 4 Podlesak Dennis SNDX Stock Option (Right to Buy) A - Award D 8,93 14 000 14 000
2018-05-25 2018-05-23 4 Legault Pierre SNDX Stock Option (Right to Buy) A - Award D 8,93 14 000 14 000
2018-05-25 2018-05-23 4 EVNIN LUKE SNDX Stock Option (Right to Buy) A - Award D 8,93 14 000 14 000
2018-04-03 2018-04-03 4 Ordentlich Peter SNDX Employee Stock Option (right to buy) M - Exercise D 3,08 −7 500 0
2018-04-03 2018-04-03 4 Ordentlich Peter SNDX Common Stock S - Sale D 15,0000 −7 500 −112 0
2018-04-03 2018-04-03 4 Ordentlich Peter SNDX Common Stock M - Exercise D 3,0800 7 500 23 7 500
2018-03-05 2018-03-01 4 Metzger Michael A SNDX Stock Option (Right to Buy) A - Award D 9,40 125 000 125 000
2018-03-05 2018-03-01 4 Meyers Michael L. SNDX Stock Option (Right to Buy) A - Award D 9,40 75 000 75 000
2018-03-05 2018-03-01 4 Morrison Briggs SNDX Stock Option (Right to Buy) A - Award D 9,40 200 000 200 000
2018-03-05 2018-03-01 4 Ordentlich Peter SNDX Stock Option (Right to Buy) A - Award D 9,40 40 000 40 000
2018-03-05 2018-03-01 4 Shea Richard P SNDX Stock Option (Right to Buy) A - Award D 9,40 48 000 48 000
2018-02-12 2018-02-08 4 Chen Henry SNDX Stock Option (Right to Buy) A - Award D 9,63 10 000 10 000
2018-02-12 2018-02-08 4 Egros Fabrice SNDX Stock Option (Right to Buy) A - Award D 9,63 10 000 10 000
2018-02-12 2018-02-08 4 EVNIN LUKE SNDX Stock Option (Right to Buy) A - Award D 9,63 10 000 10 000
2018-02-12 2018-02-08 4 Katkin Keith SNDX Stock Option (Right to Buy) A - Award D 9,63 10 000 10 000
2018-02-12 2018-02-08 4 Legault Pierre SNDX Stock Option (Right to Buy) A - Award D 9,63 10 000 10 000
2018-02-12 2018-02-08 4 Podlesak Dennis SNDX Stock Option (Right to Buy) A - Award D 9,63 10 000 10 000
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 3 924 968
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 4 504 500
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 3 924 968
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 3 174 868
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 4 504 500
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 4 504 500
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 3 924 968
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 3 174 868
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 4 504 500
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 3 924 968
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 3 174 868
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 4 504 500
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 3 924 968
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 3 174 868
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 4 504 500
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 3 924 968
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 3 174 868
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 4 504 500
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 3 924 968
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 3 174 868
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 4 504 500
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 3 174 868
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 3 924 968
2017-12-08 3 BVF PARTNERS L P/IL SNDX Common Stock, $0.0001 par value per share D 3 174 868
2017-05-19 2017-05-17 4 Chen Henry SNDX Stock Option (Right to Buy) A - Award D 13,58 5 000 5 000
2017-05-19 2017-05-17 4 Chen Henry SNDX Stock Option (Right to Buy) A - Award D 13,58 10 000 10 000
2017-05-19 2017-05-17 4 Egros Fabrice SNDX Stock Option (Right to Buy) A - Award D 13,58 5 000 5 000
2017-05-19 2017-05-17 4 Egros Fabrice SNDX Stock Option (Right to Buy) A - Award D 13,58 10 000 10 000
2017-05-19 2017-05-17 4 EVNIN LUKE SNDX Stock Option (Right to Buy) A - Award D 13,58 5 000 5 000
2017-05-19 2017-05-17 4 EVNIN LUKE SNDX Stock Option (Right to Buy) A - Award D 13,58 10 000 10 000
2017-05-19 2017-05-17 4 Katkin Keith SNDX Stock Option (Right to Buy) A - Award D 13,58 10 000 10 000
2017-05-19 2017-05-17 4 Legault Pierre SNDX Stock Option (Right to Buy) A - Award D 13,58 5 000 5 000
2017-05-19 2017-05-17 4 Legault Pierre SNDX Stock Option (Right to Buy) A - Award D 13,58 10 000 10 000
2017-05-19 2017-05-17 4 Podlesak Dennis SNDX Stock Option (Right to Buy) A - Award D 13,58 5 000 5 000
2017-05-19 2017-05-17 4 Podlesak Dennis SNDX Stock Option (Right to Buy) A - Award D 13,58 10 000 10 000
2017-05-19 2017-05-17 4 Sledge George W. Jr. SNDX Stock Options (Right to buy) A - Award D 13,58 5 000 5 000
2017-05-19 2017-05-17 4 Ordentlich Peter SNDX Employee Stock Option (right to buy) M - Exercise D 3,08 −732 0
2017-05-19 2017-05-17 4 Ordentlich Peter SNDX Common Stock S - Sale D 15,0000 −5 000 −75 0
2017-05-19 2017-05-17 4 Ordentlich Peter SNDX Common Stock M - Exercise D 3,0800 732 2 5 000
2017-03-31 2017-03-29 4 Katkin Keith SNDX Stock Option (Right to Buy) A - Award D 13,78 25 000 25 000
2017-03-22 2017-03-20 4 ROYSTON IVOR SNDX Common Stock D - Sale to Issuer I 13,7500 −125 000 −1 719 625 545
2017-02-15 2017-02-13 4 Shea Richard P SNDX Stock Option (Right to Buy) A - Award D 10,20 125 000 125 000
2017-02-08 2017-02-06 4 Metzger Michael A SNDX Stock Option (Right to Buy) A - Award D 8,77 95 000 95 000
2017-02-08 2017-02-06 4 Meyers Michael L. SNDX Stock Option (Right to Buy) A - Award D 8,77 66 100 66 100
2017-02-08 2017-02-06 4 Morrison Briggs SNDX Stock Option (Right to Buy) A - Award D 8,77 160 000 160 000
2017-02-08 2017-02-06 4 Ordentlich Peter SNDX Stock Option (Right to Buy) A - Award D 8,77 20 000 20 000
2017-01-05 2017-01-04 4 Legault Pierre SNDX Stock Option (Right to Buy) A - Award D 7,08 20 000 20 000
2016-11-02 2016-10-31 4 EVNIN LUKE SNDX Stock Option (Right to Buy) A - Award D 11,81 8 000 8 000
2016-11-02 2016-10-31 4 Podlesak Dennis SNDX Stock Option (Right to Buy) A - Award D 11,81 8 000 8 000
2016-11-02 2016-10-31 4 ROYSTON IVOR SNDX Stock Option (Right to Buy) A - Award D 11,81 8 000 8 000
2016-11-02 2016-10-31 4 Shea Richard P SNDX Stock Option (Right to Buy) A - Award D 11,81 8 000 8 000
2016-11-02 2016-10-31 4 Kamdar Kim P. SNDX Stock Option (Right to Buy) A - Award D 11,81 8 000 8 000
2016-11-02 2016-10-31 4 Egros Fabrice SNDX Stock Option (Right to Buy) A - Award D 11,81 8 000 8 000
2016-11-02 2016-10-31 4 Sledge George W. Jr. SNDX Stock Option (Right to Buy) A - Award D 11,81 8 000 8 000
2016-11-02 2016-10-31 4 Chen Henry SNDX Stock Options (Right to buy) A - Award D 11,81 8 000 8 000
2016-03-09 2016-03-08 4 MPM BioVentures IV QP LP SNDX Series C-1 Preferred Stock C - Conversion I −312 085 0
2016-03-09 2016-03-08 4 MPM BioVentures IV QP LP SNDX Series B-1 Preferred Stock C - Conversion I −718 396 0
2016-03-09 2016-03-08 4 MPM BioVentures IV QP LP SNDX Series A-1 Preferred Stock C - Conversion I −1 138 210 0
2016-03-09 2016-03-08 4 MPM BioVentures IV QP LP SNDX Common Stock C - Conversion I 312 085 2 168 691
2016-03-09 2016-03-08 4 MPM BioVentures IV QP LP SNDX Common Stock C - Conversion I 718 396 1 856 606
2016-03-09 2016-03-08 4 MPM BioVentures IV QP LP SNDX Common Stock C - Conversion I 1 138 210 1 138 210
2016-03-08 2016-03-08 4 Domain Partners VI, L.P. SNDX Series B-1 Preferred Stock C - Conversion D −444 460 0
2016-03-08 2016-03-08 4 Domain Partners VI, L.P. SNDX Series A-1 Preferred Stock C - Conversion D −1 299 394 0
2016-03-08 2016-03-08 4 Domain Partners VI, L.P. SNDX Common Stock C - Conversion D 1 743 854 1 743 854
2016-03-08 2016-03-08 4 DP VI Associates, L.P. SNDX Series A-1 Preferred Stock C - Conversion D −13 925 0
2016-03-08 2016-03-08 4 DP VI Associates, L.P. SNDX Common Stock C - Conversion D 13 925 13 925
2016-03-08 2016-03-08 4 EVNIN LUKE SNDX Series C-1 Preferred Stock C - Conversion I −312 085 0
2016-03-08 2016-03-08 4 EVNIN LUKE SNDX Series B-1 Preferred Stock C - Conversion I −718 396 0
2016-03-08 2016-03-08 4 EVNIN LUKE SNDX Series A-1 Preferred Stock C - Conversion I −1 138 210 0
2016-03-08 2016-03-08 4 EVNIN LUKE SNDX Common Stock C - Conversion I 312 085 2 168 691
2016-03-08 2016-03-08 4 EVNIN LUKE SNDX Common Stock C - Conversion I 718 396 1 856 606
2016-03-08 2016-03-08 4 EVNIN LUKE SNDX Common Stock C - Conversion I 1 138 210 1 138 210
2016-03-08 2016-03-08 4 ROYSTON IVOR SNDX Series C-1 Preferred Stock C - Conversion I −86 419 0
2016-03-08 2016-03-08 4 ROYSTON IVOR SNDX Series B-1 Preferred Stock C - Conversion I −198 931 0
2016-03-08 2016-03-08 4 ROYSTON IVOR SNDX Series A-1 Preferred Stock C - Conversion I −315 195 0
2016-03-08 2016-03-08 4 ROYSTON IVOR SNDX Common Stock P - Purchase I 12,0000 150 000 1 800 750 545
2016-03-08 2016-03-08 4 ROYSTON IVOR SNDX Common Stock C - Conversion I 86 419 600 545
2016-03-08 2016-03-08 4 ROYSTON IVOR SNDX Common Stock C - Conversion I 198 931 514 126
2016-03-08 2016-03-08 4 ROYSTON IVOR SNDX Common Stock C - Conversion I 315 195 315 195
2016-03-08 2016-03-08 4 DP VIII Associates, L.P. SNDX Series C-1 Preferred Stock C - Conversion D −2 674 0
2016-03-08 2016-03-08 4 DP VIII Associates, L.P. SNDX Series B-1 Preferred Stock C - Conversion D −2 967 0
2016-03-08 2016-03-08 4 DP VIII Associates, L.P. SNDX Common Stock C - Conversion D 5 641 5 641
2016-03-08 2016-03-08 4 Domain Partners VIII, L.P. SNDX Series C-1 Preferred Stock C - Conversion D −360 640 0
2016-03-08 2016-03-08 4 Domain Partners VIII, L.P. SNDX Series B-1 Preferred Stock C - Conversion D −400 422 0
2016-03-08 2016-03-08 4 Domain Partners VIII, L.P. SNDX Common Stock C - Conversion D 761 062 761 062
2016-03-02 3 Ordentlich Peter SNDX Common Stock D 8 536
2016-03-02 3 Ordentlich Peter SNDX Common Stock D 8 536
2016-03-02 3 Shah Nimesh SNDX Common Stock D 27 128
2016-03-02 3 Shah Nimesh SNDX Common Stock D 27 128
2016-03-02 3 Shah Nimesh SNDX Common Stock D 27 128
2016-03-02 3 Shah Nimesh SNDX Common Stock D 27 128
2016-03-02 3 Shah Nimesh SNDX Common Stock D 27 128
2016-03-02 3 Shah Nimesh SNDX Common Stock D 27 128
2016-03-02 3 Shah Nimesh SNDX Common Stock D 27 128
2016-03-02 3 Shah Nimesh SNDX Common Stock D 27 128
2016-03-02 3 Shah Nimesh SNDX Common Stock D 27 128
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
Other Listings
DE:1T3 12,40 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista